{
    "clinical_study": {
        "@rank": "92318", 
        "acronym": "Diabetes", 
        "arm_group": {
            "arm_group_label": "Diabetic patients", 
            "description": "Un balanced diabetic patients"
        }, 
        "biospec_descr": {
            "textblock": "Whole blood for UCP2 mRNA"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "Many patients with Diabetes find difficulties in achieving glycemic control. Hemoglobin\n      A1c(HgBA1c) is used as a marker for glycemic control. UCP2 is affected by high glucose\n      levels, high free fatty acids and high oxidative stress.\n\n      The investigators intend to learn about the changes in UCP2 along the process of reaching\n      glycemic control."
        }, 
        "brief_title": "Changes in Mitochondrial Uncoupling Protein 2 (UCP2) Messenger RNA(mRNA) in Type 2 Diabetes (T2DM) Patients", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Diabetes", 
        "condition_browse": {
            "mesh_term": "Diabetes Mellitus"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Un balanced diabetic patients.\n\n        Exclusion Criteria:\n\n          -  No current infection."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "20 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Un balanced diabetic patients"
            }
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01781754", 
            "org_study_id": "TASMC-11-NV-561-CTIL"
        }, 
        "intervention": {
            "arm_group_label": "Diabetic patients", 
            "description": "This is the only intervention that is part of the study. A family physician or other physician will be responsible of the diabetic treatment (common treatment, e.g Metformin).", 
            "intervention_name": "Blood withdrawal", 
            "intervention_type": "Procedure"
        }, 
        "intervention_browse": {
            "mesh_term": "Mitochondrial uncoupling protein 2"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Glycemic control", 
            "Metabolic control", 
            "Oxidative stress", 
            "Diabetes"
        ], 
        "lastchanged_date": "January 30, 2013", 
        "location": {
            "contact": {
                "email": "vaisman@tasmc.health.gov.il", 
                "last_name": "Nachum Vaisman, MD", 
                "phone": "972-3-6974807"
            }, 
            "facility": {
                "address": {
                    "city": "Tel-Aviv", 
                    "country": "Israel", 
                    "zip": "64239"
                }, 
                "name": "Tel Aviv Sourasky Medical Center"
            }, 
            "investigator": {
                "last_name": "Nachum Vaisman, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_groups": "1", 
        "official_title": "Changes in UCP2 mRNA in T2DM Patients", 
        "overall_contact": {
            "email": "vaisman@tasmc.health.gov.il", 
            "last_name": "Nachum Vaisman, MD", 
            "phone": "972-3-6974807"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Checking UCP2 levels compared to HgBA1c", 
            "measure": "Levels of gene expression for UCP2 (RQ)", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "reference": [
            {
                "PMID": "15936305", 
                "citation": "Dmitriev AD, Factor MI, Segal OL, Pavlova EV, Massino YS, Smirnova MB, Yakovleva DA, Dmitriev DA, Kizim EA, Kolyaskina GI, Brusov OS. Western blot analysis of human and rat serotonin transporter in platelets and brain using site-specific antibodies: evidence that transporter undergoes endoproteolytic cleavage. Clin Chim Acta. 2005 Jun;356(1-2):76-94. Epub 2005 Mar 17."
            }, 
            {
                "PMID": "16373902", 
                "citation": "Rudofsky G Jr, Schroedter A, Schlotterer A, Voron'ko OE, Schlimme M, Tafel J, Isermann BH, Humpert PM, Morcos M, Bierhaus A, Nawroth PP, Hamann A. Functional polymorphisms of UCP2 and UCP3 are associated with a reduced prevalence of diabetic neuropathy in patients with type 1 diabetes. Diabetes Care. 2006 Jan;29(1):89-94."
            }, 
            {
                "PMID": "11502224", 
                "citation": "Dulloo AG, Samec S. Uncoupling proteins: their roles in adaptive thermogenesis and substrate metabolism reconsidered. Br J Nutr. 2001 Aug;86(2):123-39. Review."
            }, 
            {
                "PMID": "12110661", 
                "citation": "Schrauwen P, Hesselink M. UCP2 and UCP3 in muscle controlling body metabolism. J Exp Biol. 2002 Aug;205(Pt 15):2275-85. Review."
            }, 
            {
                "PMID": "15647715", 
                "citation": "Rendel M. Advances in diabetes for the millennium: nutritional therapy of type 2 diabetes. MedGenMed. 2004 Sep 1;6(3 Suppl):10. Review."
            }, 
            {
                "PMID": "15738989", 
                "citation": "Krauss S, Zhang CY, Lowell BB. The mitochondrial uncoupling-protein homologues. Nat Rev Mol Cell Biol. 2005 Mar;6(3):248-61. Review."
            }, 
            {
                "PMID": "16283557", 
                "citation": "Boreck\u00fd J, Vercesi AE. Plant uncoupling mitochondrial protein and alternative oxidase: energy metabolism and stress. Biosci Rep. 2005 Jun-Aug;25(3-4):271-86. Review."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01781754"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Glycemic control (glucose level and HgA1c), levels of free reactive oxygen species (ROS) and non-esterified fatty acids (NEFAs).", 
            "measure": "Improved metabolic state", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "source": "Tel-Aviv Sourasky Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Tel-Aviv Sourasky Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2013"
    }
}